Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.99067501 |
2 | L-phenylalanine catabolic process (GO:0006559) | 4.99067501 |
3 | L-phenylalanine metabolic process (GO:0006558) | 4.49817483 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.49817483 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 4.33522255 |
6 | establishment of mitochondrion localization (GO:0051654) | 3.96893149 |
7 | indole-containing compound catabolic process (GO:0042436) | 3.79497027 |
8 | indolalkylamine catabolic process (GO:0046218) | 3.79497027 |
9 | tryptophan catabolic process (GO:0006569) | 3.79497027 |
10 | cellular ketone body metabolic process (GO:0046950) | 3.79113538 |
11 | bile acid biosynthetic process (GO:0006699) | 3.72635833 |
12 | postsynaptic membrane organization (GO:0001941) | 3.68671372 |
13 | dendritic spine morphogenesis (GO:0060997) | 3.66967719 |
14 | neuron recognition (GO:0008038) | 3.65362366 |
15 | axonal fasciculation (GO:0007413) | 3.61860797 |
16 | kynurenine metabolic process (GO:0070189) | 3.56218637 |
17 | tryptophan metabolic process (GO:0006568) | 3.53492778 |
18 | urea metabolic process (GO:0019627) | 3.52436030 |
19 | urea cycle (GO:0000050) | 3.52436030 |
20 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.48635793 |
21 | auditory behavior (GO:0031223) | 3.43469546 |
22 | alpha-linolenic acid metabolic process (GO:0036109) | 3.38965341 |
23 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.38678545 |
24 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.36097746 |
25 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.35709470 |
26 | coenzyme catabolic process (GO:0009109) | 3.35617889 |
27 | glutamate metabolic process (GO:0006536) | 3.35430618 |
28 | glyoxylate metabolic process (GO:0046487) | 3.33470511 |
29 | righting reflex (GO:0060013) | 3.32966561 |
30 | behavioral response to nicotine (GO:0035095) | 3.29597089 |
31 | ketone body metabolic process (GO:1902224) | 3.28852281 |
32 | mitochondrion transport along microtubule (GO:0047497) | 3.24961334 |
33 | establishment of mitochondrion localization, microtubule-mediated (GO:0034643) | 3.24961334 |
34 | neuron cell-cell adhesion (GO:0007158) | 3.24518136 |
35 | vocalization behavior (GO:0071625) | 3.23376748 |
36 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.23212243 |
37 | * neurotransmitter-gated ion channel clustering (GO:0072578) | 3.20394026 |
38 | cysteine metabolic process (GO:0006534) | 3.20035072 |
39 | nitrogen cycle metabolic process (GO:0071941) | 3.19508132 |
40 | synapse assembly (GO:0007416) | 3.18387330 |
41 | gamma-aminobutyric acid transport (GO:0015812) | 3.18323463 |
42 | high-density lipoprotein particle remodeling (GO:0034375) | 3.17411248 |
43 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.16338333 |
44 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.15915196 |
45 | bile acid metabolic process (GO:0008206) | 3.14196503 |
46 | synaptic vesicle exocytosis (GO:0016079) | 3.06971250 |
47 | nucleobase catabolic process (GO:0046113) | 3.05800905 |
48 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 3.05496220 |
49 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.04855079 |
50 | startle response (GO:0001964) | 3.01984575 |
51 | aromatic amino acid family metabolic process (GO:0009072) | 3.01181351 |
52 | tyrosine metabolic process (GO:0006570) | 3.00874961 |
53 | alpha-amino acid catabolic process (GO:1901606) | 2.93387348 |
54 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.93325530 |
55 | complement activation, alternative pathway (GO:0006957) | 2.91302282 |
56 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.90088039 |
57 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.89328252 |
58 | mechanosensory behavior (GO:0007638) | 2.89306801 |
59 | regulation of bile acid biosynthetic process (GO:0070857) | 2.88659934 |
60 | glutamate secretion (GO:0014047) | 2.87353375 |
61 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.86856403 |
62 | presynaptic membrane assembly (GO:0097105) | 2.86431636 |
63 | neuromuscular synaptic transmission (GO:0007274) | 2.86108712 |
64 | behavioral response to cocaine (GO:0048148) | 2.85986397 |
65 | neuronal ion channel clustering (GO:0045161) | 2.85473561 |
66 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.83728240 |
67 | regulation of fibrinolysis (GO:0051917) | 2.81973894 |
68 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.81943279 |
69 | protein carboxylation (GO:0018214) | 2.81943279 |
70 | short-chain fatty acid metabolic process (GO:0046459) | 2.81887239 |
71 | macromolecular complex remodeling (GO:0034367) | 2.81820226 |
72 | plasma lipoprotein particle remodeling (GO:0034369) | 2.81820226 |
73 | protein-lipid complex remodeling (GO:0034368) | 2.81820226 |
74 | neurotransmitter secretion (GO:0007269) | 2.81562367 |
75 | C4-dicarboxylate transport (GO:0015740) | 2.81316177 |
76 | glutamate receptor signaling pathway (GO:0007215) | 2.81102988 |
77 | drug catabolic process (GO:0042737) | 2.80230218 |
78 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.79667422 |
79 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.79504670 |
80 | regulation of protein activation cascade (GO:2000257) | 2.79176489 |
81 | indolalkylamine metabolic process (GO:0006586) | 2.78965115 |
82 | lysine catabolic process (GO:0006554) | 2.78902533 |
83 | lysine metabolic process (GO:0006553) | 2.78902533 |
84 | sulfur amino acid catabolic process (GO:0000098) | 2.77983794 |
85 | dicarboxylic acid catabolic process (GO:0043649) | 2.77896642 |
86 | transmission of nerve impulse (GO:0019226) | 2.77071919 |
87 | cellular amino acid catabolic process (GO:0009063) | 2.75945056 |
88 | reverse cholesterol transport (GO:0043691) | 2.75921923 |
89 | presynaptic membrane organization (GO:0097090) | 2.75368885 |
90 | negative regulation of fibrinolysis (GO:0051918) | 2.74902431 |
91 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.74377083 |
92 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.73349595 |
93 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.72879490 |
94 | cellular modified amino acid catabolic process (GO:0042219) | 2.72462215 |
95 | retinal ganglion cell axon guidance (GO:0031290) | 2.71087351 |
96 | protein localization to synapse (GO:0035418) | 2.70827533 |
97 | response to auditory stimulus (GO:0010996) | 2.69625400 |
98 | amine catabolic process (GO:0009310) | 2.69394910 |
99 | cellular biogenic amine catabolic process (GO:0042402) | 2.69394910 |
100 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.69070459 |
101 | low-density lipoprotein particle remodeling (GO:0034374) | 2.68953702 |
102 | cerebellar granule cell differentiation (GO:0021707) | 2.68680522 |
103 | regulation of cholesterol esterification (GO:0010872) | 2.68375428 |
104 | homocysteine metabolic process (GO:0050667) | 2.67176047 |
105 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.67107967 |
106 | locomotory exploration behavior (GO:0035641) | 2.66954942 |
107 | neuron-neuron synaptic transmission (GO:0007270) | 2.66582826 |
108 | regulation of neurotransmitter levels (GO:0001505) | 2.66549891 |
109 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.66391193 |
110 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 2.66137139 |
111 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.64864674 |
112 | acylglycerol homeostasis (GO:0055090) | 2.63363121 |
113 | triglyceride homeostasis (GO:0070328) | 2.63363121 |
114 | exogenous drug catabolic process (GO:0042738) | 2.63330426 |
115 | limb bud formation (GO:0060174) | 2.63097609 |
116 | membrane depolarization during action potential (GO:0086010) | 2.62532759 |
117 | regulation of synapse structural plasticity (GO:0051823) | 2.61705101 |
118 | behavioral response to ethanol (GO:0048149) | 2.61682290 |
119 | serine family amino acid catabolic process (GO:0009071) | 2.61072736 |
120 | fatty acid elongation (GO:0030497) | 2.59013552 |
121 | regulation of female receptivity (GO:0045924) | 2.58296338 |
122 | nonmotile primary cilium assembly (GO:0035058) | 2.57825290 |
123 | regulation of complement activation (GO:0030449) | 2.57547010 |
124 | cell migration in hindbrain (GO:0021535) | 2.56837660 |
125 | acetyl-CoA metabolic process (GO:0006084) | 2.56349166 |
126 | synaptic transmission, glutamatergic (GO:0035249) | 2.56281423 |
127 | succinate metabolic process (GO:0006105) | 2.55545793 |
128 | regulation of triglyceride catabolic process (GO:0010896) | 2.54660965 |
129 | female mating behavior (GO:0060180) | 2.54548867 |
130 | indole-containing compound metabolic process (GO:0042430) | 2.53902811 |
131 | protein polyglutamylation (GO:0018095) | 2.53279557 |
132 | dendrite morphogenesis (GO:0048813) | 2.53205397 |
133 | positive regulation of synapse assembly (GO:0051965) | 2.52964170 |
134 | cholesterol efflux (GO:0033344) | 2.52759007 |
135 | synaptic vesicle maturation (GO:0016188) | 2.52029575 |
136 | cofactor catabolic process (GO:0051187) | 2.51294320 |
137 | aspartate family amino acid catabolic process (GO:0009068) | 2.51254415 |
138 | central nervous system neuron axonogenesis (GO:0021955) | 2.51229531 |
139 | regulation of respiratory system process (GO:0044065) | 2.50314521 |
140 | neuronal action potential propagation (GO:0019227) | 2.49957653 |
141 | very long-chain fatty acid metabolic process (GO:0000038) | 2.49599447 |
142 | benzene-containing compound metabolic process (GO:0042537) | 2.48740187 |
143 | * synapse organization (GO:0050808) | 2.48709906 |
144 | synaptic vesicle endocytosis (GO:0048488) | 2.47151020 |
145 | neurotransmitter transport (GO:0006836) | 2.46340798 |
146 | dendritic spine organization (GO:0097061) | 2.46210405 |
147 | negative regulation of dendrite development (GO:2000171) | 2.45252127 |
148 | reflex (GO:0060004) | 2.45051712 |
149 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.43535494 |
150 | adult walking behavior (GO:0007628) | 2.41957846 |
151 | positive regulation of mitochondrial fission (GO:0090141) | 2.41779035 |
152 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.40990643 |
153 | proline transport (GO:0015824) | 2.40454454 |
154 | hippocampus development (GO:0021766) | 2.39963489 |
155 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339) | 2.39505728 |
156 | regulation of synaptic vesicle transport (GO:1902803) | 2.34189009 |
157 | adult behavior (GO:0030534) | 2.33886958 |
158 | central nervous system myelination (GO:0022010) | 2.33744356 |
159 | axon ensheathment in central nervous system (GO:0032291) | 2.33744356 |
160 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.31391615 |
161 | behavioral defense response (GO:0002209) | 2.29556086 |
162 | behavioral fear response (GO:0001662) | 2.29556086 |
163 | regulation of synapse assembly (GO:0051963) | 2.28403178 |
164 | sympathetic nervous system development (GO:0048485) | 2.28322345 |
165 | synaptic transmission, cholinergic (GO:0007271) | 2.27181686 |
166 | regulation of postsynaptic membrane potential (GO:0060078) | 2.26612039 |
167 | neurotransmitter catabolic process (GO:0042135) | 2.24464693 |
168 | exploration behavior (GO:0035640) | 2.23713806 |
169 | regulation of collateral sprouting (GO:0048670) | 2.23561100 |
170 | synaptic transmission (GO:0007268) | 2.23428466 |
171 | negative regulation of axon extension (GO:0030517) | 2.22365386 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.64898722 |
2 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.57709553 |
3 | * GBX2_23144817_ChIP-Seq_PC3_Human | 3.40420962 |
4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.64985032 |
5 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.46071174 |
6 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 2.43050757 |
7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.36687047 |
8 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.36015011 |
9 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.23444281 |
10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.23286638 |
11 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.11111201 |
12 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.07571727 |
13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.00637036 |
14 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.99069705 |
15 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.98090584 |
16 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.94499499 |
17 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.94262060 |
18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.92184275 |
19 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.91075351 |
20 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.89542078 |
21 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.89542078 |
22 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.89541590 |
23 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.86528677 |
24 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.79903221 |
25 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.78923442 |
26 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.77536573 |
27 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.77269350 |
28 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.76689780 |
29 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.76238938 |
30 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.75313225 |
31 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.75010685 |
32 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.72922729 |
33 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.70980774 |
34 | P300_19829295_ChIP-Seq_ESCs_Human | 1.61754586 |
35 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.60794799 |
36 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.59974702 |
37 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.59094509 |
38 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.58650328 |
39 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.58559247 |
40 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.58521618 |
41 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.55304180 |
42 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.54409084 |
43 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.53406584 |
44 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.53236350 |
45 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.52166121 |
46 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.49497837 |
47 | EWS_26573619_Chip-Seq_HEK293_Human | 1.47603693 |
48 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.45624839 |
49 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.45601436 |
50 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.45286223 |
51 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.45170182 |
52 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.44492830 |
53 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.43720169 |
54 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.38559210 |
55 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.37002656 |
56 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.34859257 |
57 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.31815712 |
58 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.31607562 |
59 | AR_25329375_ChIP-Seq_VCAP_Human | 1.28905682 |
60 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.24236700 |
61 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.23082568 |
62 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.21903173 |
63 | * MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.21574104 |
64 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.21349402 |
65 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 1.21293536 |
66 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.21060423 |
67 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.19521264 |
68 | * FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.19070272 |
69 | * SOX9_26525672_Chip-Seq_HEART_Mouse | 1.18883767 |
70 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.18301805 |
71 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.17249612 |
72 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.16402456 |
73 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.15261520 |
74 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15021265 |
75 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.14840155 |
76 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.14712312 |
77 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.14159117 |
78 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.12775270 |
79 | * KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.12596756 |
80 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.10785909 |
81 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.10016838 |
82 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.07432655 |
83 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.07168170 |
84 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.06824148 |
85 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.06824148 |
86 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.06625529 |
87 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.06533660 |
88 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.06283564 |
89 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.04734671 |
90 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.04682021 |
91 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.04682021 |
92 | * RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.03801073 |
93 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.03026454 |
94 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.02084124 |
95 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.01936922 |
96 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.01863523 |
97 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.01403331 |
98 | FUS_26573619_Chip-Seq_HEK293_Human | 1.01373356 |
99 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.00642872 |
100 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.00156810 |
101 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.99914021 |
102 | * CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99525950 |
103 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.98683615 |
104 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.98456634 |
105 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.98084844 |
106 | * AR_19668381_ChIP-Seq_PC3_Human | 0.97065755 |
107 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.96814473 |
108 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.96727701 |
109 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 0.96004187 |
110 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.95641961 |
111 | KDM2B_26808549_Chip-Seq_REH_Human | 0.95545330 |
112 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.95365463 |
113 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.95312083 |
114 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.95312083 |
115 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.94922507 |
116 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.94832682 |
117 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.93108839 |
118 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.93053787 |
119 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.92679735 |
120 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.92355660 |
121 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.92100185 |
122 | VDR_22108803_ChIP-Seq_LS180_Human | 0.91630299 |
123 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.90910268 |
124 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.90363080 |
125 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.89096805 |
126 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89016812 |
127 | TCF4_22108803_ChIP-Seq_LS180_Human | 0.87472216 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 4.85092612 |
2 | MP0005360_urolithiasis | 4.63909695 |
3 | MP0005085_abnormal_gallbladder_physiolo | 3.72967644 |
4 | MP0005365_abnormal_bile_salt | 3.57246164 |
5 | MP0004859_abnormal_synaptic_plasticity | 3.35791115 |
6 | MP0003880_abnormal_central_pattern | 3.30396844 |
7 | MP0008875_abnormal_xenobiotic_pharmacok | 3.23044965 |
8 | MP0002822_catalepsy | 2.96938391 |
9 | MP0003635_abnormal_synaptic_transmissio | 2.62786593 |
10 | MP0004270_analgesia | 2.48306454 |
11 | MP0009745_abnormal_behavioral_response | 2.41930843 |
12 | MP0002063_abnormal_learning/memory/cond | 2.23087050 |
13 | MP0002064_seizures | 2.20612237 |
14 | MP0010329_abnormal_lipoprotein_level | 2.15864326 |
15 | MP0009046_muscle_twitch | 2.12866256 |
16 | MP0002572_abnormal_emotion/affect_behav | 1.98809794 |
17 | MP0003252_abnormal_bile_duct | 1.98133125 |
18 | MP0003122_maternal_imprinting | 1.96386777 |
19 | MP0003329_amyloid_beta_deposits | 1.95135538 |
20 | MP0001486_abnormal_startle_reflex | 1.90888806 |
21 | MP0003195_calcinosis | 1.90845671 |
22 | * MP0002272_abnormal_nervous_system | 1.89947064 |
23 | MP0003787_abnormal_imprinting | 1.89689060 |
24 | MP0001501_abnormal_sleep_pattern | 1.88159392 |
25 | MP0009780_abnormal_chondrocyte_physiolo | 1.82910608 |
26 | MP0005332_abnormal_amino_acid | 1.80306434 |
27 | MP0001984_abnormal_olfaction | 1.76339233 |
28 | MP0005423_abnormal_somatic_nervous | 1.72317374 |
29 | MP0002102_abnormal_ear_morphology | 1.71149366 |
30 | MP0001968_abnormal_touch/_nociception | 1.68691180 |
31 | MP0001440_abnormal_grooming_behavior | 1.68599111 |
32 | MP0002876_abnormal_thyroid_physiology | 1.68062675 |
33 | MP0002734_abnormal_mechanical_nocicepti | 1.64840083 |
34 | MP0005187_abnormal_penis_morphology | 1.64244047 |
35 | MP0000566_synostosis | 1.62038675 |
36 | MP0005646_abnormal_pituitary_gland | 1.58147605 |
37 | MP0003690_abnormal_glial_cell | 1.55672038 |
38 | MP0003806_abnormal_nucleotide_metabolis | 1.53253744 |
39 | MP0002837_dystrophic_cardiac_calcinosis | 1.53217322 |
40 | MP0005083_abnormal_biliary_tract | 1.52120079 |
41 | MP0000631_abnormal_neuroendocrine_gland | 1.44633810 |
42 | MP0001188_hyperpigmentation | 1.43083725 |
43 | MP0005394_taste/olfaction_phenotype | 1.42893007 |
44 | MP0005499_abnormal_olfactory_system | 1.42893007 |
45 | MP0001502_abnormal_circadian_rhythm | 1.40344399 |
46 | MP0003121_genomic_imprinting | 1.40172155 |
47 | MP0002118_abnormal_lipid_homeostasis | 1.39464589 |
48 | MP0001666_abnormal_nutrient_absorption | 1.39339199 |
49 | MP0000604_amyloidosis | 1.37454895 |
50 | * MP0002067_abnormal_sensory_capabilities | 1.37215255 |
51 | MP0006276_abnormal_autonomic_nervous | 1.36317672 |
52 | MP0005551_abnormal_eye_electrophysiolog | 1.36212778 |
53 | MP0005535_abnormal_body_temperature | 1.33425402 |
54 | MP0002735_abnormal_chemical_nociception | 1.32692792 |
55 | MP0004142_abnormal_muscle_tone | 1.30666622 |
56 | MP0003868_abnormal_feces_composition | 1.30362656 |
57 | MP0000778_abnormal_nervous_system | 1.30302019 |
58 | MP0002736_abnormal_nociception_after | 1.30031337 |
59 | MP0004145_abnormal_muscle_electrophysio | 1.27032329 |
60 | MP0002751_abnormal_autonomic_nervous | 1.25512375 |
61 | MP0002234_abnormal_pharynx_morphology | 1.24383312 |
62 | * MP0005386_behavior/neurological_phenoty | 1.23493081 |
63 | * MP0004924_abnormal_behavior | 1.23493081 |
64 | MP0002733_abnormal_thermal_nociception | 1.20052392 |
65 | MP0002557_abnormal_social/conspecific_i | 1.19735597 |
66 | MP0002184_abnormal_innervation | 1.13536592 |
67 | MP0004019_abnormal_vitamin_homeostasis | 1.12686468 |
68 | MP0004043_abnormal_pH_regulation | 1.12523066 |
69 | MP0003633_abnormal_nervous_system | 1.10008612 |
70 | MP0002638_abnormal_pupillary_reflex | 1.09516636 |
71 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.09296285 |
72 | MP0001970_abnormal_pain_threshold | 1.08555299 |
73 | MP0008789_abnormal_olfactory_epithelium | 1.08185420 |
74 | MP0004885_abnormal_endolymph | 1.07119252 |
75 | MP0002152_abnormal_brain_morphology | 1.06679337 |
76 | MP0001905_abnormal_dopamine_level | 1.06107763 |
77 | MP0008569_lethality_at_weaning | 1.05600741 |
78 | MP0003879_abnormal_hair_cell | 1.05358944 |
79 | MP0004133_heterotaxia | 1.04508461 |
80 | MP0008877_abnormal_DNA_methylation | 1.04134322 |
81 | MP0005253_abnormal_eye_physiology | 1.03889529 |
82 | MP0005645_abnormal_hypothalamus_physiol | 1.03691882 |
83 | MP0002090_abnormal_vision | 1.02062269 |
84 | * MP0002752_abnormal_somatic_nervous | 1.00965882 |
85 | MP0002138_abnormal_hepatobiliary_system | 1.00745192 |
86 | MP0002653_abnormal_ependyma_morphology | 1.00542745 |
87 | MP0006072_abnormal_retinal_apoptosis | 1.00283197 |
88 | MP0004130_abnormal_muscle_cell | 0.99155985 |
89 | * MP0002066_abnormal_motor_capabilities/c | 0.98363732 |
90 | MP0002938_white_spotting | 0.97842663 |
91 | MP0000569_abnormal_digit_pigmentation | 0.96717226 |
92 | MP0001346_abnormal_lacrimal_gland | 0.96692968 |
93 | MP0003631_nervous_system_phenotype | 0.94995730 |
94 | MP0006292_abnormal_olfactory_placode | 0.94567605 |
95 | * MP0001529_abnormal_vocalization | 0.94350447 |
96 | MP0009697_abnormal_copulation | 0.91943817 |
97 | MP0000026_abnormal_inner_ear | 0.91905691 |
98 | MP0002909_abnormal_adrenal_gland | 0.91688953 |
99 | MP0001764_abnormal_homeostasis | 0.91291975 |
100 | MP0003119_abnormal_digestive_system | 0.90791761 |
101 | MP0000920_abnormal_myelination | 0.89454966 |
102 | MP0001485_abnormal_pinna_reflex | 0.89091947 |
103 | * MP0003861_abnormal_nervous_system | 0.88569045 |
104 | * MP0002229_neurodegeneration | 0.88342080 |
105 | MP0002928_abnormal_bile_duct | 0.87033842 |
106 | MP0009840_abnormal_foam_cell | 0.86475361 |
107 | * MP0000955_abnormal_spinal_cord | 0.86231838 |
108 | * MP0002069_abnormal_eating/drinking_beha | 0.85314820 |
109 | * MP0002882_abnormal_neuron_morphology | 0.84590417 |
110 | MP0002254_reproductive_system_inflammat | 0.83925940 |
111 | MP0008872_abnormal_physiological_respon | 0.83190607 |
112 | MP0008874_decreased_physiological_sensi | 0.83138217 |
113 | MP0000609_abnormal_liver_physiology | 0.82915497 |
114 | MP0003890_abnormal_embryonic-extraembry | 0.82323713 |
115 | MP0001963_abnormal_hearing_physiology | 0.81978185 |
116 | MP0002078_abnormal_glucose_homeostasis | 0.81878256 |
117 | MP0005319_abnormal_enzyme/_coenzyme | 0.80602258 |
118 | MP0004811_abnormal_neuron_physiology | 0.79958827 |
119 | MP0003283_abnormal_digestive_organ | 0.78126649 |
120 | MP0005670_abnormal_white_adipose | 0.77324323 |
121 | MP0001986_abnormal_taste_sensitivity | 0.76130455 |
122 | MP0003646_muscle_fatigue | 0.75110544 |
123 | MP0003632_abnormal_nervous_system | 0.74785429 |
124 | MP0000647_abnormal_sebaceous_gland | 0.71254245 |
125 | MP0005448_abnormal_energy_balance | 0.69978309 |
126 | MP0001177_atelectasis | 0.69737563 |
127 | MP0003137_abnormal_impulse_conducting | 0.69465169 |
128 | MP0004742_abnormal_vestibular_system | 0.68410897 |
129 | * MP0005195_abnormal_posterior_eye | 0.67721571 |
130 | MP0003075_altered_response_to | 0.67475827 |
131 | MP0004215_abnormal_myocardial_fiber | 0.66198007 |
132 | MP0002971_abnormal_brown_adipose | 0.66109876 |
133 | MP0010386_abnormal_urinary_bladder | 0.65714946 |
134 | MP0005647_abnormal_sex_gland | 0.65421376 |
135 | MP0005451_abnormal_body_composition | 0.65353954 |
136 | MP0002233_abnormal_nose_morphology | 0.64841926 |
137 | MP0003315_abnormal_perineum_morphology | 0.64812832 |
138 | MP0004085_abnormal_heartbeat | 0.64263076 |
139 | MP0003011_delayed_dark_adaptation | 0.63847134 |
140 | MP0002160_abnormal_reproductive_system | 0.63218485 |
141 | MP0003634_abnormal_glial_cell | 0.62717868 |
142 | MP0003191_abnormal_cellular_cholesterol | 0.62664343 |
143 | MP0003183_abnormal_peptide_metabolism | 0.62487411 |
144 | MP0006035_abnormal_mitochondrial_morpho | 0.61875212 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Focal motor seizures (HP:0011153) | 4.89253887 |
2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 4.73792275 |
3 | Intrahepatic cholestasis (HP:0001406) | 4.52788960 |
4 | Deep venous thrombosis (HP:0002625) | 4.28864008 |
5 | Prolonged partial thromboplastin time (HP:0003645) | 4.08028102 |
6 | Hyperventilation (HP:0002883) | 4.01195949 |
7 | Hypobetalipoproteinemia (HP:0003563) | 3.87980203 |
8 | Xanthomatosis (HP:0000991) | 3.64059613 |
9 | Hyperlipoproteinemia (HP:0010980) | 3.55722282 |
10 | Myokymia (HP:0002411) | 3.48975729 |
11 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.33514169 |
12 | Limb dystonia (HP:0002451) | 3.33195288 |
13 | Focal seizures (HP:0007359) | 3.32909219 |
14 | Ketosis (HP:0001946) | 3.22731722 |
15 | Gait imbalance (HP:0002141) | 3.18355560 |
16 | Epidermoid cyst (HP:0200040) | 3.15779089 |
17 | Epileptic encephalopathy (HP:0200134) | 3.15172312 |
18 | Atonic seizures (HP:0010819) | 3.04855184 |
19 | Complement deficiency (HP:0004431) | 3.03565455 |
20 | Ketoacidosis (HP:0001993) | 2.97609375 |
21 | Febrile seizures (HP:0002373) | 2.93368872 |
22 | Absence seizures (HP:0002121) | 2.85678081 |
23 | Conjugated hyperbilirubinemia (HP:0002908) | 2.81847169 |
24 | Hyperglycinemia (HP:0002154) | 2.79162661 |
25 | Neurofibrillary tangles (HP:0002185) | 2.78128984 |
26 | Hyperammonemia (HP:0001987) | 2.77719062 |
27 | Hypolipoproteinemia (HP:0010981) | 2.75112885 |
28 | Generalized tonic-clonic seizures (HP:0002069) | 2.74660252 |
29 | Medial flaring of the eyebrow (HP:0010747) | 2.69425182 |
30 | Congenital primary aphakia (HP:0007707) | 2.67078544 |
31 | Status epilepticus (HP:0002133) | 2.64560926 |
32 | Dialeptic seizures (HP:0011146) | 2.64397640 |
33 | Abnormality of glycine metabolism (HP:0010895) | 2.55425108 |
34 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.55425108 |
35 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.52787201 |
36 | Nephrogenic diabetes insipidus (HP:0009806) | 2.51901176 |
37 | Joint hemorrhage (HP:0005261) | 2.51821285 |
38 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.51209745 |
39 | Progressive cerebellar ataxia (HP:0002073) | 2.51067941 |
40 | Hyperglycinuria (HP:0003108) | 2.49265947 |
41 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.47883333 |
42 | Cerebral inclusion bodies (HP:0100314) | 2.47520032 |
43 | Fat malabsorption (HP:0002630) | 2.46743869 |
44 | Abnormality of methionine metabolism (HP:0010901) | 2.46380391 |
45 | Lissencephaly (HP:0001339) | 2.45000348 |
46 | Abnormality of the common coagulation pathway (HP:0010990) | 2.42347171 |
47 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.42090008 |
48 | Pheochromocytoma (HP:0002666) | 2.40036547 |
49 | Renal cortical cysts (HP:0000803) | 2.39302952 |
50 | Abnormality of the labia minora (HP:0012880) | 2.36296115 |
51 | Visual hallucinations (HP:0002367) | 2.36228137 |
52 | Drooling (HP:0002307) | 2.35648455 |
53 | Excessive salivation (HP:0003781) | 2.35648455 |
54 | Abnormal gallbladder physiology (HP:0012438) | 2.33344111 |
55 | Cholecystitis (HP:0001082) | 2.33344111 |
56 | Blue irides (HP:0000635) | 2.33143234 |
57 | Hemiparesis (HP:0001269) | 2.32751722 |
58 | Nephronophthisis (HP:0000090) | 2.32329990 |
59 | Gout (HP:0001997) | 2.31749374 |
60 | Cerebral edema (HP:0002181) | 2.29507099 |
61 | Epileptiform EEG discharges (HP:0011182) | 2.27320678 |
62 | Hypoalphalipoproteinemia (HP:0003233) | 2.27107658 |
63 | Pancreatic cysts (HP:0001737) | 2.23381025 |
64 | Retinal dysplasia (HP:0007973) | 2.22930514 |
65 | Specific learning disability (HP:0001328) | 2.22019680 |
66 | Vaginal atresia (HP:0000148) | 2.20944945 |
67 | Exercise-induced myalgia (HP:0003738) | 2.20546019 |
68 | Pachygyria (HP:0001302) | 2.19428003 |
69 | EEG with generalized epileptiform discharges (HP:0011198) | 2.19010587 |
70 | Dysdiadochokinesis (HP:0002075) | 2.18752625 |
71 | Torticollis (HP:0000473) | 2.18032264 |
72 | Genital tract atresia (HP:0001827) | 2.14948834 |
73 | Abnormality of the corticospinal tract (HP:0002492) | 2.14241888 |
74 | Action tremor (HP:0002345) | 2.12946590 |
75 | Abnormal gallbladder morphology (HP:0012437) | 2.12228658 |
76 | Dysmetria (HP:0001310) | 2.11128799 |
77 | True hermaphroditism (HP:0010459) | 2.10945543 |
78 | Sensorimotor neuropathy (HP:0007141) | 2.10330371 |
79 | Hypercholesterolemia (HP:0003124) | 2.09595801 |
80 | Hypsarrhythmia (HP:0002521) | 2.09298418 |
81 | Urinary urgency (HP:0000012) | 2.08946336 |
82 | Fair hair (HP:0002286) | 2.07836413 |
83 | Neuroendocrine neoplasm (HP:0100634) | 2.07733365 |
84 | Metabolic acidosis (HP:0001942) | 2.07600777 |
85 | Poor suck (HP:0002033) | 2.07146619 |
86 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.06047924 |
87 | Acute encephalopathy (HP:0006846) | 2.05568964 |
88 | Anxiety (HP:0000739) | 2.05208424 |
89 | Type II lissencephaly (HP:0007260) | 2.04207233 |
90 | Cortical dysplasia (HP:0002539) | 2.03465124 |
91 | Cholelithiasis (HP:0001081) | 2.03306116 |
92 | Craniofacial dystonia (HP:0012179) | 2.03276066 |
93 | Focal dystonia (HP:0004373) | 2.03272189 |
94 | Spontaneous abortion (HP:0005268) | 2.02852059 |
95 | Skin nodule (HP:0200036) | 2.01675349 |
96 | Scanning speech (HP:0002168) | 2.01172329 |
97 | Impaired social interactions (HP:0000735) | 2.00451496 |
98 | Abnormal social behavior (HP:0012433) | 2.00451496 |
99 | Acute necrotizing encephalopathy (HP:0006965) | 1.99439319 |
100 | Spastic gait (HP:0002064) | 1.99260050 |
101 | Oligodactyly (hands) (HP:0001180) | 1.98389346 |
102 | Abnormal eating behavior (HP:0100738) | 1.97751117 |
103 | Methylmalonic acidemia (HP:0002912) | 1.97328377 |
104 | Broad-based gait (HP:0002136) | 1.97066084 |
105 | Spastic tetraplegia (HP:0002510) | 1.96578595 |
106 | Poor coordination (HP:0002370) | 1.92824342 |
107 | Lethargy (HP:0001254) | 1.92478058 |
108 | Muscular hypotonia of the trunk (HP:0008936) | 1.90745235 |
109 | Abnormality of purine metabolism (HP:0004352) | 1.90300789 |
110 | Abnormality of the renal medulla (HP:0100957) | 1.90209165 |
111 | Delayed CNS myelination (HP:0002188) | 1.90068552 |
112 | Pancreatic fibrosis (HP:0100732) | 1.88298156 |
113 | Absent speech (HP:0001344) | 1.88106525 |
114 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.87720966 |
115 | Hyperbilirubinemia (HP:0002904) | 1.87602951 |
116 | Supranuclear gaze palsy (HP:0000605) | 1.87091719 |
117 | Abnormality of the renal cortex (HP:0011035) | 1.87033977 |
118 | Poor eye contact (HP:0000817) | 1.86995695 |
119 | Abnormality of serum amino acid levels (HP:0003112) | 1.86984592 |
120 | Tubulointerstitial nephritis (HP:0001970) | 1.85508281 |
121 | Abnormality of the intrinsic pathway (HP:0010989) | 1.84869457 |
122 | Polyphagia (HP:0002591) | 1.84791876 |
123 | Intention tremor (HP:0002080) | 1.84694885 |
124 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.84539738 |
125 | Hypoplasia of the brainstem (HP:0002365) | 1.84440118 |
126 | Aplasia/Hypoplasia of the brainstem (HP:0007362) | 1.84440118 |
127 | Generalized myoclonic seizures (HP:0002123) | 1.83004019 |
128 | Inability to walk (HP:0002540) | 1.82519444 |
129 | Hepatocellular necrosis (HP:0001404) | 1.82510073 |
130 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.82357920 |
131 | Hypochromic microcytic anemia (HP:0004840) | 1.81853325 |
132 | Hypoglycemic coma (HP:0001325) | 1.81552146 |
133 | Ankle clonus (HP:0011448) | 1.81477307 |
134 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.81104380 |
135 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.80697089 |
136 | Progressive macrocephaly (HP:0004481) | 1.80681035 |
137 | Irritability (HP:0000737) | 1.80475774 |
138 | Optic nerve hypoplasia (HP:0000609) | 1.80256965 |
139 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.79226239 |
140 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.79226239 |
141 | Abnormality of the gallbladder (HP:0005264) | 1.78554794 |
142 | Abnormality of midbrain morphology (HP:0002418) | 1.77072114 |
143 | Molar tooth sign on MRI (HP:0002419) | 1.77072114 |
144 | Amblyopia (HP:0000646) | 1.76479494 |
145 | Gaze-evoked nystagmus (HP:0000640) | 1.75940223 |
146 | Failure to thrive in infancy (HP:0001531) | 1.75599764 |
147 | Hepatic necrosis (HP:0002605) | 1.73522308 |
148 | Colon cancer (HP:0003003) | 1.72969535 |
149 | Fetal akinesia sequence (HP:0001989) | 1.70935892 |
150 | Chronic hepatic failure (HP:0100626) | 1.68033496 |
151 | Exotropia (HP:0000577) | 1.66537885 |
152 | Mitochondrial inheritance (HP:0001427) | 1.64046795 |
153 | Renal hypoplasia (HP:0000089) | 1.63990068 |
154 | Hepatoblastoma (HP:0002884) | 1.63911705 |
155 | Agitation (HP:0000713) | 1.63574436 |
156 | Intestinal atresia (HP:0011100) | 1.63195525 |
157 | Anophthalmia (HP:0000528) | 1.62254083 |
158 | Astrocytoma (HP:0009592) | 1.62034585 |
159 | Abnormality of the astrocytes (HP:0100707) | 1.62034585 |
160 | Dyskinesia (HP:0100660) | 1.61944715 |
161 | Hypoplasia of the corpus callosum (HP:0002079) | 1.61315131 |
162 | Amyotrophic lateral sclerosis (HP:0007354) | 1.57950827 |
163 | Hypothermia (HP:0002045) | 1.54896285 |
164 | Increased CSF lactate (HP:0002490) | 1.54542273 |
Rank | Gene Set | Z-score |
---|---|---|
1 | EPHA4 | 4.11193882 |
2 | CASK | 3.20624002 |
3 | NTRK3 | 3.19777242 |
4 | MARK1 | 2.86197971 |
5 | MAP3K4 | 2.71986025 |
6 | MAP2K7 | 2.47723070 |
7 | MAP2K4 | 2.27706932 |
8 | MAP4K2 | 2.26300591 |
9 | DAPK2 | 1.90073801 |
10 | MINK1 | 1.82216113 |
11 | TNIK | 1.81753024 |
12 | OXSR1 | 1.79015640 |
13 | INSRR | 1.75235690 |
14 | NTRK2 | 1.67943347 |
15 | DYRK2 | 1.65798909 |
16 | ERBB4 | 1.65760780 |
17 | SGK494 | 1.54127479 |
18 | SGK223 | 1.54127479 |
19 | MAP3K9 | 1.53430568 |
20 | RIPK4 | 1.49321419 |
21 | BCKDK | 1.44408702 |
22 | PHKG1 | 1.43223016 |
23 | PHKG2 | 1.43223016 |
24 | SGK2 | 1.36643845 |
25 | PRPF4B | 1.34076902 |
26 | TRIM28 | 1.32825621 |
27 | CCNB1 | 1.30958556 |
28 | CSNK1G1 | 1.29604834 |
29 | MAPK13 | 1.28624023 |
30 | PAK6 | 1.28568443 |
31 | ERBB3 | 1.25974595 |
32 | STK39 | 1.25220053 |
33 | PRKCG | 1.19539026 |
34 | MAP3K12 | 1.18172073 |
35 | FGFR2 | 1.15172678 |
36 | CDK5 | 1.12927045 |
37 | GRK5 | 1.12579620 |
38 | PKN1 | 1.12070495 |
39 | KSR1 | 1.11836519 |
40 | TAOK3 | 1.10141691 |
41 | SGK3 | 1.08556187 |
42 | CAMK2A | 1.07967509 |
43 | AKT3 | 1.07149745 |
44 | CSNK1G2 | 1.03731157 |
45 | PINK1 | 1.02712033 |
46 | OBSCN | 1.02116946 |
47 | BCR | 1.01307106 |
48 | NTRK1 | 0.99158799 |
49 | KSR2 | 0.98002370 |
50 | PLK2 | 0.95918487 |
51 | MAP3K6 | 0.95002072 |
52 | SIK1 | 0.92621616 |
53 | CAMK2B | 0.92251218 |
54 | SIK2 | 0.91790294 |
55 | WNK4 | 0.90513602 |
56 | GRK7 | 0.90430541 |
57 | WNK3 | 0.89685481 |
58 | EPHA3 | 0.88869338 |
59 | PAK3 | 0.88514940 |
60 | PIK3CA | 0.87773456 |
61 | BMPR2 | 0.87395324 |
62 | FRK | 0.85057670 |
63 | CDK19 | 0.83742291 |
64 | MAP3K2 | 0.80815083 |
65 | CAMK2G | 0.79929299 |
66 | TSSK6 | 0.79490734 |
67 | CAMK1D | 0.78276393 |
68 | MKNK2 | 0.78148518 |
69 | PRKCZ | 0.77471257 |
70 | MUSK | 0.76490366 |
71 | CAMK1G | 0.76307586 |
72 | ARAF | 0.75658288 |
73 | EPHB2 | 0.75286910 |
74 | PRKCE | 0.75262283 |
75 | PDPK1 | 0.74207623 |
76 | FGFR4 | 0.74102832 |
77 | VRK1 | 0.73913188 |
78 | SGK1 | 0.72765506 |
79 | NME1 | 0.72761942 |
80 | MAP3K7 | 0.72579621 |
81 | MAP3K13 | 0.72132378 |
82 | FGR | 0.71491286 |
83 | BMPR1B | 0.71317467 |
84 | CAMKK1 | 0.70338142 |
85 | FES | 0.69843654 |
86 | MAPK12 | 0.66888771 |
87 | PNCK | 0.66818855 |
88 | PRKCH | 0.66752628 |
89 | PRKAA1 | 0.66352885 |
90 | PDK1 | 0.65560036 |
91 | STK38 | 0.65058139 |
92 | CDK14 | 0.64889739 |
93 | CDK15 | 0.64352334 |
94 | TYRO3 | 0.63379451 |
95 | CSNK1G3 | 0.63241263 |
96 | SIK3 | 0.62753003 |
97 | RET | 0.62717455 |
98 | DAPK1 | 0.62490153 |
99 | CAMK2D | 0.61158678 |
100 | ZAK | 0.60996531 |
101 | MAPKAPK5 | 0.59530741 |
102 | ADRBK2 | 0.59446910 |
103 | UHMK1 | 0.58651426 |
104 | LMTK2 | 0.57467071 |
105 | STK11 | 0.57379306 |
106 | CAMK4 | 0.57256612 |
107 | CSNK1A1L | 0.57159355 |
108 | PDK4 | 0.57027268 |
109 | PDK3 | 0.57027268 |
110 | CSNK1A1 | 0.56796233 |
111 | CDK11A | 0.56437476 |
112 | WNK1 | 0.56368815 |
113 | NEK1 | 0.55960578 |
114 | GRK1 | 0.55342331 |
115 | LIMK1 | 0.55068214 |
116 | DYRK1A | 0.54512577 |
117 | CAMKK2 | 0.53992079 |
118 | PRKACG | 0.52269868 |
119 | DYRK3 | 0.51548237 |
120 | MARK2 | 0.51396764 |
121 | MAPK7 | 0.51332783 |
122 | CSNK1E | 0.50965355 |
123 | NEK6 | 0.50691611 |
124 | EPHB1 | 0.49827202 |
125 | SRPK1 | 0.49769980 |
126 | CDK18 | 0.49277264 |
127 | CAMK1 | 0.48862973 |
128 | PRKACA | 0.48212916 |
129 | PRKD3 | 0.47411098 |
130 | CSNK1D | 0.44862587 |
131 | MKNK1 | 0.44150728 |
132 | * RPS6KA3 | 0.41894972 |
133 | ERBB2 | 0.40038479 |
134 | PRKCI | 0.38851214 |
135 | PRKDC | 0.38374837 |
136 | PRKG1 | 0.36480507 |
137 | STK38L | 0.36396051 |
138 | RPS6KB1 | 0.34741872 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.20454360 |
2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.05495241 |
3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.92652584 |
4 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.36742388 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.36587407 |
6 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.33616947 |
7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.19971600 |
8 | Nicotine addiction_Homo sapiens_hsa05033 | 2.12718396 |
9 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.05257825 |
10 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.92507868 |
11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.87005975 |
12 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.85976116 |
13 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.82413158 |
14 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.71093399 |
15 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.68191466 |
16 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.64780339 |
17 | * GABAergic synapse_Homo sapiens_hsa04727 | 1.56707515 |
18 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.56609049 |
19 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.52117860 |
20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.51388470 |
21 | Peroxisome_Homo sapiens_hsa04146 | 1.47332036 |
22 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.46931207 |
23 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.45535515 |
24 | Parkinsons disease_Homo sapiens_hsa05012 | 1.43305839 |
25 | Bile secretion_Homo sapiens_hsa04976 | 1.42699495 |
26 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.41777111 |
27 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.40619597 |
28 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.38368086 |
29 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.33899688 |
30 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.31446252 |
31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.30303703 |
32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.30276957 |
33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.28556680 |
34 | Protein export_Homo sapiens_hsa03060 | 1.27898731 |
35 | Histidine metabolism_Homo sapiens_hsa00340 | 1.27775418 |
36 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.27248259 |
37 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.26861058 |
38 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.23994755 |
39 | Morphine addiction_Homo sapiens_hsa05032 | 1.23658156 |
40 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.19286883 |
41 | Circadian entrainment_Homo sapiens_hsa04713 | 1.19264439 |
42 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.16956826 |
43 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.15368491 |
44 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.12972448 |
45 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.03750548 |
46 | Olfactory transduction_Homo sapiens_hsa04740 | 1.03211848 |
47 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.02470937 |
48 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.97242564 |
49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.95967893 |
50 | Retinol metabolism_Homo sapiens_hsa00830 | 0.95757098 |
51 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.94306857 |
52 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.93808155 |
53 | Taste transduction_Homo sapiens_hsa04742 | 0.93800703 |
54 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.92802446 |
55 | Huntingtons disease_Homo sapiens_hsa05016 | 0.92279105 |
56 | Long-term potentiation_Homo sapiens_hsa04720 | 0.92037636 |
57 | Insulin secretion_Homo sapiens_hsa04911 | 0.89930608 |
58 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.88834397 |
59 | Salivary secretion_Homo sapiens_hsa04970 | 0.88743808 |
60 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.83865505 |
61 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.77923897 |
62 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.77019821 |
63 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.77018980 |
64 | ABC transporters_Homo sapiens_hsa02010 | 0.76537944 |
65 | Renin secretion_Homo sapiens_hsa04924 | 0.75837412 |
66 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.75258561 |
67 | Cocaine addiction_Homo sapiens_hsa05030 | 0.74802464 |
68 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.73128053 |
69 | Basal transcription factors_Homo sapiens_hsa03022 | 0.69083729 |
70 | Carbon metabolism_Homo sapiens_hsa01200 | 0.67234468 |
71 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.66384671 |
72 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.66260819 |
73 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.66187081 |
74 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.65815487 |
75 | Long-term depression_Homo sapiens_hsa04730 | 0.65619510 |
76 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.64711148 |
77 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.64524158 |
78 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.64134377 |
79 | Gap junction_Homo sapiens_hsa04540 | 0.64083657 |
80 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.63297408 |
81 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.62766336 |
82 | RNA polymerase_Homo sapiens_hsa03020 | 0.61950398 |
83 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.61336687 |
84 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.59987704 |
85 | Alcoholism_Homo sapiens_hsa05034 | 0.59312641 |
86 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.59194951 |
87 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.59135120 |
88 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.59050114 |
89 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.56481322 |
90 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.56471427 |
91 | Phototransduction_Homo sapiens_hsa04744 | 0.56356625 |
92 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.56161135 |
93 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.55921867 |
94 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.55626176 |
95 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.54902780 |
96 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.54795632 |
97 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.52995631 |
98 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.50994567 |
99 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50048267 |
100 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.49673804 |
101 | Sulfur relay system_Homo sapiens_hsa04122 | 0.49257849 |
102 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.48999960 |
103 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.46930959 |
104 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.46337610 |
105 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.46132377 |
106 | Alzheimers disease_Homo sapiens_hsa05010 | 0.45942894 |
107 | RNA degradation_Homo sapiens_hsa03018 | 0.45000624 |
108 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.44969788 |
109 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44798342 |
110 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.43285189 |
111 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.42817168 |
112 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.42778602 |
113 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.41709003 |
114 | Prion diseases_Homo sapiens_hsa05020 | 0.40336923 |
115 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.34613357 |
116 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.33154905 |
117 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.32839760 |
118 | Axon guidance_Homo sapiens_hsa04360 | 0.32696777 |
119 | Circadian rhythm_Homo sapiens_hsa04710 | 0.30991802 |
120 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.30505020 |